Candida Fratazzi
BBCR Consulting, USA
Biography
Candida Fratazzi devised the concept of SCIO, cost-effective trial design, and streamlining solutions. She has been involved in the development of several biosimilars. As President of BBCR, she acts as a consultant to biotech, pharmaceutical, medical device companies and investors. She is a renowned Immunologist and has over 15 years of experience in Orphan Drug development. She is the recipient of 2013, 2014 and 2015 Best Pharmaceutical Consultant, Cambridge Award and 2014 top ranked US Executives. She helps international companies to enter the US and EU markets. She has had her training at the Johns Hopkins University, Harvard University and at Imperial College in London, UK.
Abstract
Abstract : Biosimilar globalization- A silver lining in untested waters